Results 181 to 190 of about 452,560 (309)

Infection control in the brain and the eye

Acta Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source

Extended Antibiotic Spacer use in an Infected Total Knee Arthroplasty with Mycobacterium intracellulare - A Case Report. [PDF]

J Orthop Case Rep
Kumar J, Fawcett M, Gulzar M, Lopez A, Shaner J.   +4 more
europepmc   +1 more source

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations

Acta Paediatrica, EarlyView.
ABSTRACT Aim The tuberculosis (TB) vaccine, Bacille‐Calmette‐Guérin (BCG), protects infants against severe forms of primary TB. Yet, it does not protect against pulmonary reactivation TB in adults. Methods A literature review was conducted between 1st January and 28th February 2025 using PubMed, Google Scholar and reports of the World Health ...
Stefan H. E. Kaufmann
wiley   +1 more source

Non-tuberculous Mycobacterial pulmonary disease due to novel mycobacterium: Mycobacterium habikinoensis: a case report. [PDF]

BMC Infect Dis
Maeda K, Tamura Y, Nagai Y, Kariya Y, Katsuta H, Ajiro N, Yoshida H, Han Y, Hashimoto S, Chikamatsu K, Takaki A, Matsumoto Y, Fatimah RM, Tanaka M, Nakamura S, Iida T, Mitarai S, Nagai T.   +17 more
europepmc   +1 more source

Improving the use of expert opinion in disease risk analysis for conservation translocations

Conservation Biology, EarlyView.
Abstract Conservation translocations are subject to considerable uncertainty and risk, of which disease is one of the most recognized. To address disease risks, several protocols for qualitative disease risk analysis (qDRA) exist and are used for responsible conservation translocation planning.
John G. Ewen, Stefano Canessa, Caitlin E. Andrews, Katie M. Beckmann, Irene Bueno, Deidre K. Fontenot, Caio Kenup, Suzanne Medina, Axel Moehrenschlager, Francesco Origgi, Bruce Rideout, Anthony W. Sainsbury, Thierry M. Work, Claudia Carraro   +13 more
wiley   +1 more source

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification

Frontiers in Pharmacology, 2022
Hendra Gunosewoyo, Gert Kruger
doaj   +1 more source

Plasmid-mediated macrolide resistance among rapidly growing mycobacteria in Japan. [PDF]

JAC Antimicrob Resist
Komine T, Sathianpitayakul P, Sakagami N, Yoshida M, Suzuki M, Hoshino Y, Ratthawongjirakul P, Ato M, Fukano H.   +8 more
europepmc   +1 more source

Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp, Nicolai Deresz, Henning Klapproth, Isabelle Suárez, Jonathan Jantsch, Mario Fabri, Esther von Stebut   +6 more
wiley   +1 more source

Mycobacterium.

Bacteriological reviews, 2010
[This corrects the article on p. 217 in vol. 41.].
openaire   +1 more source

A phase therapy regimen containing clofazimine manifested high efficacy in treating Mycobacterium abscessus pulmonary disease. [PDF]

BMC Pulm Med
Bao S, Chen S, Huang H, Duan H.
europepmc   +1 more source